Sort
166,118 grants matching “stem cells”
Sex Differences in Cardiometabolic Health and Disease
$1,497,580Karen Reue · University Of California Los Angeles · U54 · FY2023 · HL
SYNERGISTIC MULTIMODALITY ANTIBODY THERAPY
$1,497,565University Of California Davis · P01 · FY2000 · CA
Identification of Genes Involved in Major Mood Disorders
$1,497,299Francis J McMahon · National Institute Of Mental Health · ZIA · FY2016 · MH
Functional Genomics of Bipolar Disorder
$1,497,299Francis J McMahon · National Institute Of Mental Health · ZIA · FY2016 · MH
Sex Differences in Cardiometabolic Health and Disease
$1,497,077Karen Reue · University Of California Los Angeles · U54 · FY2025 · HL
Gene Therapy for Inherited Blood Disorders
$1,497,052Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Building the Posterior Lateral Line system In Zebrafish Embryos
$1,496,894Ajay B Chitnis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
GENE THERAPY APPROACHES FOR BLOOD AND VASCULAR DISEASES
$1,496,835City Of Hope/Beckman Research Institute · P01 · FY2004 · HL
Gene targeted rat resource for the study of complex disease
$1,496,596Melinda R Dwinell · Medical College Of Wisconsin · R24 · FY2017 · HL
improving outcomes after stem cell transplantation
$1,496,532Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
$1,496,446Michael A Pulsipher · Children'S Hospital Of Los Angeles · U01 · FY2018 · AI
IGF::OT::IGF: SBIR PHASE II, TOPIC 326: DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS
$1,496,276Jagath Junutula · Cellerant Therapeutics, Inc. · N44 · FY2016 · CA
IGF::OT::IGF: FASTING MIMICKING DIETES AND IMMUNOSENESCENCE
$1,495,733Todd Morgan · L-Nutra, Inc. · N43 · FY2015 · AG
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder
$1,495,500John R Kelsoe · University Of California, San Diego · U01 · FY2010 · MH
Gene and Cell Therapy of Duchenne Muscular Dystrophy
$1,495,446University Of Pittsburgh At Pittsburgh · U54 · FY2005 · AR
Biomarkers of Catecholaminergic Neurodegeneration
$1,495,263David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Emory Specialized Center of Research Excellence (SCORE) on Sex Differences
$1,495,232Ighovwerha Ofotokun · Emory University · U54 · FY2020 · AG
GENE THERAPY FOR EPIDERMOLYSIS BULLOSA
$1,495,045Stanford University · P01 · FY2001 · AR
Application of Flow Cytometry to Cell Biology
$1,494,868Susan Sharrow · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Multi-omic understanding of the transformed host T-cell response to HIV following therapeutic vaccination
$1,494,209Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2023 · AI
Pathogenesis and Treatment of Muscular Dystrophy
$1,494,202Louis M Kunkel · Boston Children'S Hospital · P50 · FY2009 · NS
CD8+ T cells and Immunological Tumor Regression
$1,493,912Hans Schreiber · University Of Chicago · P01 · FY2009 · CA
Northwestern Uterine Leiomyoma Research Center
$1,493,788Serdar E Bulun · Northwestern University At Chicago · P50 · FY2019 · HD
Preclinical assessment of a novel compound for treating radiation-induced oral mucositis
$1,493,635Colton Joseph Lloyd · Sinopia Biosciences, Inc. · R44 · FY2024 · DE
Early Pathogenesis of Cystic Fibrosis Related Diabetes
$1,493,139John F Engelhardt · University Of Iowa · RC2 · FY2021 · DK